Nicolás M S Gálvez (Nicolás Ms Gálvez, N M S Galvez, Nicolas M S Galvez)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Viruses

Vaccines

Virulence

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Nicolás M S Gálvez, Maegan L Sheehan, Allen Z Lin, Yi Cao, Evan C Lam, Abigail M Jackson, Alejandro B Balazs
QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro. Viruses 16 (8) (2024)
Nicolás M S Gálvez, Maegan L Sheehan, Allen Z Lin, Yi Cao, Evan C Lam, Abigail M Jackson, Alejandro B Balazs
QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro. Viruses 16 (8) (2024)
Jorge A Soto, Nicolás M S Gálvez, D B Rivera, F E Díaz, C A Riedel, Susan M Bueno, Alexis M Kalergis
From animal studies into clinical trials: the relevance of animal models to develop vaccines and therapies to reduce disease severity and prevent hRSV infection. Expert opinion on drug discovery (2022)
Katia Abarca, Carolina Iturriaga, Marcela Urzúa, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, González Pa, Susan M Bueno, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M Pérez, Marcela Potin, Álvaro Rojas, José Vicente González-Aramundiz, Nicolás M S Gálvez, Francisca Aguirre-Boza, Sofía Aljaro, Luis Federico Batiz, Yessica Campisto, Mariela Cepeda, Aarón Cortés, Sofía López, María Loreto Pérez, Andrea Schilling, Alexis M Kalergis, null On Behalf Of The CoronaVac Cl Study Group
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial. Vaccines 10 (7) (2022)
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, Nicolás M S Gálvez, Gaspar A Pacheco, Jorge A Soto, Roslye V Berríos-Rojas, Liliana A González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Catalina A Andrade, Omar P Vallejos, Alejandro Piña-Iturbe, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, null null, José V González-Aramundiz, González Pa, Katia Abarca, Alexis M Kalergis, Susan M Bueno
A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern. mBio 13 (4) (2022)
Bárbara M Schultz, Felipe Melo-González, Luisa F Duarte, Nicolás M S Gálvez, Gaspar A Pacheco, Jorge A Soto, Roslye V Berríos-Rojas, Liliana A González, Daniela Moreno-Tapia, Daniela Rivera-Pérez, Mariana Ríos, Yaneisi Vázquez, Guillermo Hoppe-Elsholz, Omar P Vallejos, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, null null, José Vicente González-Aramundiz, González Pa, Katia Abarca, Alexis M Kalergis, Susan M Bueno
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concern. medRxiv : the preprint server for health sciences (2022)
Jorge A Soto, Fabián E Díaz, Angello Retamal-Díaz, Nicolás M S Gálvez, Felipe Melo-González, Alejandro Piña-Iturbe, Mario A Ramírez, Karen Bohmwald, González Pa, Susan M Bueno, Alexis M Kalergis
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus . Vaccines 10 (5) (2022)
Nicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, Felipe Melo-González, Jorge A Soto, Luisa F Duarte, Liliana A González, Daniela Rivera-Pérez, Mariana Ríos, Roslye V Berrios, Yaneisi Vázquez, Daniela Moreno-Tapia, Omar P Vallejos, Catalina A Andrade, Guillermo Hoppe-Elsholz, Carolina Iturriaga, Marcela Urzua, María S Navarrete, Álvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Mónica L Acevedo, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alba Grifoni, Alessandro Sette, Gang Zeng, Weining Meng, null null, José V González-Aramundiz, Marina Johnson, David Goldblatt, González Pa, Katia Abarca, Susan M Bueno, Alexis M Kalergis
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial. eLife 11 (2022)
Gaspar A Pacheco, Nicolás M S Gálvez, Jorge A Soto, Catalina A Andrade, Alexis M Kalergis
Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus. Microorganisms 9 (6) (2021)
Susan M Bueno, Katia Abarca, Pablo A González, Nicolás M S Gálvez, Jorge A Soto, Luisa F Duarte, Bárbara M Schultz, Gaspar A Pacheco, Liliana A González, Yaneisi Vázquez, Mariana Ríos, Felipe Melo-González, Daniela Rivera-Pérez, Carolina Iturriaga, Marcela Urzúa, Angélica Dominguez, Catalina A Andrade, Roslye V Berrios, Gisela Canedo-Marroquín, Camila Covián, Daniela Moreno-Tapia, Farides Saavedra, Omar P Vallejos, Paulina Donato, Pilar Espinoza, Daniela Fuentes, Marcela González, Paula Guzmán, Paula Muñoz-Venturelli, Carlos M Pérez, Marcela Potin, Alvaro Rojas, Rodrigo Fasce, Jorge Fernández, Judith Mora, Eugenio Ramírez, Aracelly Gaete-Argel, Aarón Oyarzún-Arrau, Fernando Valiente-Echeverría, Ricardo Soto-Rifo, Daniela Weiskopf, Alessandro Sette, Gang Zeng, Weining Meng, José V González-Aramundiz, Alexis M Kalergis
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial. medRxiv : the preprint server for health sciences (2021)
Nicolás M S Gálvez, Catalina A Andrade, Gaspar A Pacheco, Jorge A Soto, Vicente Stranger, Thomas Rivera, Abel E Vásquez, Alexis M Kalergis
Host Components That Modulate the Disease Caused by hMPV. Viruses 13 (3) (2021)
Antonia Reyes, Nicolás Corrales, Nicolás M S Gálvez, Susan M Bueno, Alexis M Kalergis, González Pa
Contribution of hypoxia inducible factor-1 during viral infections. Virulence 11 (1) (2021)
Emma Rey-Jurado, Karen Bohmwald, Nicolás M S Gálvez, Daniela Becerra, Steven A Porcelli, Leandro J Carreño, Alexis M Kalergis
Contribution of NKT cells to the immune response and pathogenesis triggered by respiratory viruses. Virulence 11 (1) (2021)
Nicolás M S Gálvez, Karen Bohmwald, Gaspar A Pacheco, Catalina A Andrade, Leandro J Carreño, Alexis M Kalergis
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases. Clinical microbiology reviews 34 (2) (2020)
Alexis M Kalergis, Jorge A Soto, Nicolás M S Gálvez, Catalina A Andrade, Ayleen Fernandez, Karen Bohmwald, Susan M Bueno
Pharmacological management of human respiratory syncytial virus infection. Expert opinion on pharmacotherapy 21 (18) (2020)

Nicolás M S Gálvez.css-eqlu8i{font-size:small;padding-left:4px;} (Nicolás Ms Gálvez, N M S Galvez, Nicolas M S Galvez)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicolás M S Gálvez (Nicolás Ms Gálvez, N M S Galvez, Nicolas M S Galvez)